The Cannabis Conversation | Medical Cannabis | CBD | Hemp
Anuj Desai
192 episodes
1 week ago
On the latest episode of The Cannabis Conversation, we speak with Dr. Franjo Grotenhermen, Chairperson at the International Association of Cannabinoid Medicines (IACM). We explore his journey into cannabis medicine, its diverse uses, and the challenges of its regulation. Together, we look at the importance of patient experiences and the need for a balance between clinical trials and real-world experiences. We also examine the risk profile of cannabis, potential side effects, contraindications...
All content for The Cannabis Conversation | Medical Cannabis | CBD | Hemp is the property of Anuj Desai and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On the latest episode of The Cannabis Conversation, we speak with Dr. Franjo Grotenhermen, Chairperson at the International Association of Cannabinoid Medicines (IACM). We explore his journey into cannabis medicine, its diverse uses, and the challenges of its regulation. Together, we look at the importance of patient experiences and the need for a balance between clinical trials and real-world experiences. We also examine the risk profile of cannabis, potential side effects, contraindications...
EPISODE #181: Why most CBD oil has low bioavailability and how to change that with Dr. Sung Min Pyo, Head of Laboratory - Enabling Pharma Excipients for BASF
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
36 minutes
2 years ago
EPISODE #181: Why most CBD oil has low bioavailability and how to change that with Dr. Sung Min Pyo, Head of Laboratory - Enabling Pharma Excipients for BASF
How effective is CBD oil?On the latest episode of The Cannabis Conversation, we’re joined by Dr Sung Min Pyo - Head of Laboratory - Enabling Pharma Excipients for BASF.A 2018 report from the World Health Organisation (WHO) estimated the bioavailability from oral consumption of CBD to be only 6% (WHO Technical Report Series 1013 - https://www.who.int/publications/i/item/9789241210225) We explore the reasons behind this estimate and discuss the bioavailability, absorption, and solubility o...
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
On the latest episode of The Cannabis Conversation, we speak with Dr. Franjo Grotenhermen, Chairperson at the International Association of Cannabinoid Medicines (IACM). We explore his journey into cannabis medicine, its diverse uses, and the challenges of its regulation. Together, we look at the importance of patient experiences and the need for a balance between clinical trials and real-world experiences. We also examine the risk profile of cannabis, potential side effects, contraindications...
